News

Santé log2h
Enara Bio Strengthens Senior Leadership with Key Executive and Board Appointments Alongside Acceleration of Multiple T-Cell Engager Programs
Enara Bio, a biopharmaceutical company pioneering the development of bispecific T-cell engagers directed against Dark Antigen® and other emerging targets, today announces the appointment of Stacey ...
Santé log2h
Roquette finalise l’acquisition d’IFF Pharma Solutions
Lille, le 1 mai 2025 – Roquette, un leader mondial des ingrédients d'origine végétale et des excipients pharmaceutiques destinés aux secteurs de la santé et de la nutrition, annonce la finalisation de ...
Santé log2h
Roquette Completes the Acquisition of IFF Pharma Solutions
Roquette is a family-owned global leader in plant-based ingredients and a leading provider of pharmaceutical excipients. Founded in 1933, the company currently operates in more than 150 countries, ...
Santé log5h
Hydreight Achieves Record Revenue and Profitability Milestone in Q4 2024 Audited Results
On April 29, 2024, Hydreight announced that it achieved record revenue and filed its audited financial statements for the fiscal year ended December 31, 2023. On March 25, 2024. Hydreight Partners ...
Santé log8h
OBI Pharma Announces U.S. FDA Clearance of IND Application for a Phase 1/2 Study of OBI-902, a Trop-2 Targeting ADC
OBI is a clinical stage global oncology company that is headquartered in Taiwan and established in 2002. Its mission, together with its wholly owned subsidiary OBI Pharma USA, Inc., is to develop ...
Santé log8h
Dimerix and Amicus Therapeutics Announce Exclusive License Agreement for DMX-200 in the United States
Dimerix Limited (ASX: DXB, “Dimerix”) and Amicus Therapeutics (Nasdaq: FOLD, “Amicus”) today announced that the two companies have entered into an exclusive license agreement for the commercialization ...
Santé log8h
SurgiBox Announces Strategic Partnership with BestBrick Medical in Taiwan
BestBrick Medical is a well-established medical distributor with over 30 years of deep-rooted presence in the Taiwanese healthcare market. BestBrick specializes in introducing innovative solutions and ...
Santé log8h
Nxera Pharma Appoints Top-Ranked Biopharma Investment Analyst Shinya Tsuzuki as Head of Investor Relations
Tokyo, Japan and Cambridge, UK, 1 May 2025 – Nxera Pharma Co., Ltd. (“Nxera” or “the Company”; TSE 4565) today announces the appointment of Shinya Tsuzuki, as Head of Investor Relations. Mr. Tsuzuki ...
Santé log11h
CD8 Technology Signs Letter of Intent for Tevogen Bio’s In-House Manufacturing Facility, Marking First Phase of Up to $50 Million Commitment
WARREN, N.J., April 30, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN) today announced that CD8 Technology Services LLC (“CD8”) has signed a letter of ...
Santé log11h
Cytokinetics to Participate in May Investor Conferences
Interested parties may access the live webcasts of the fireside chats by visiting the Investors & Media section of the Cytokinetics website at http://www.cytokinetics.com. The webcast replays will be ...
Santé log11h
Burn clinicians present positive findings of the DeepView® System’s accuracy at the American Burn Association annual meeting
This year’s meeting showcased the latest advancements in burn care, fostered interdisciplinary collaboration, and celebrated the burn care community’s dedication. Burn and Plastics Senior Registar ...
Santé log11h
Vaxart to Present at the Citizens Life Sciences Conference
SOUTH SAN FRANCISCO, Calif., April 30, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. (NASDAQ: VXRT) today announced that members of the management team will present at the Citizens Life Sciences conference ...